OpenAI acquires Orchestra Bio
Executive Summary
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
You May Also Like
Next Logical Step
ChatGPT now lets you lock your chats
The company says the feature is designed for situations where users might be discussing something personal or planning a...